← Browse by Condition
Medical Condition
latent tuberculosis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT03474029 Phase 2, Phase 3
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Enrollment
3,400 pts
Location
United States, Austr...
Sponsor
Centers for Disease Control an...
NCT01212003
Recruiting
Training Protocol on the Natural History of Tuberculosis
Enrollment
150 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT05621343
Recruiting
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
Enrollment
130 pts
Location
Sweden
Sponsor
Region Skane